Pegging Pathology on Mitochondrial Dysfunction

SYNAPTIC MITOCHONDRIA:Courtesy of Husseini ManjiThe surge in intracellular calcium during an individual action potential is rapidly buffered by mitochondrial calcium uptake. The release of calcium back into the cytoplasm is believed to allow for post-tetanic potentiation. ATP-production is essential for vesicle docking, fusion and endocytosis. Mitochondrial pathology and some treatments affect the mitochondrial membrane potential. Disrupting the MMP results in more pronounced calcium spikes; cha

Written byA Nicola Schweitzer
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Courtesy of Husseini Manji

The surge in intracellular calcium during an individual action potential is rapidly buffered by mitochondrial calcium uptake. The release of calcium back into the cytoplasm is believed to allow for post-tetanic potentiation. ATP-production is essential for vesicle docking, fusion and endocytosis. Mitochondrial pathology and some treatments affect the mitochondrial membrane potential. Disrupting the MMP results in more pronounced calcium spikes; chaotic, dysynchronized release; inhibition of endocytosis and neurotransmitter release; and rapid fatigue of various energy-dependent processes.

The mitochondrion, powerhouse of the eukaryotic cell, sits at the center of converging lines of brain-disorder research. Researchers have implicated the organelle in the pathophysiology of distinct conditions such as schizophrenia and bipolar disorder. The motif of convergence extends to results obtained by disparate approaches ranging from molecular and biochemical to clinical, and from empirical to hypothetical. In the brain, energy produced through oxidative phosphorylation in the mitochondrion not only ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies